Review



regulatory t cells treg  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems regulatory t cells treg
    Regulatory T Cells Treg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/regulatory t cells treg/product/R&D Systems
    Average 93 stars, based on 14 article reviews
    regulatory t cells treg - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    flow cytometry a mouse regulatory t cell staining kit  (Multi Sciences (Lianke) Biotech Co Ltd)
    94
    Multi Sciences (Lianke) Biotech Co Ltd flow cytometry a mouse regulatory t cell staining kit
    Flow Cytometry A Mouse Regulatory T Cell Staining Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flow cytometry a mouse regulatory t cell staining kit/product/Multi Sciences (Lianke) Biotech Co Ltd
    Average 94 stars, based on 1 article reviews
    flow cytometry a mouse regulatory t cell staining kit - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    regulatory t cells treg  (R&D Systems)
    93
    R&D Systems regulatory t cells treg
    Regulatory T Cells Treg, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/regulatory t cells treg/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    regulatory t cells treg - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    mouse regulatory t cell staining kit  (Multi Sciences (Lianke) Biotech Co Ltd)
    94
    Multi Sciences (Lianke) Biotech Co Ltd mouse regulatory t cell staining kit
    Mouse Regulatory T Cell Staining Kit, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse regulatory t cell staining kit/product/Multi Sciences (Lianke) Biotech Co Ltd
    Average 94 stars, based on 1 article reviews
    mouse regulatory t cell staining kit - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    dynabeads regulatory cd4 + cd25 + t-cell kit (>95% purity tested by flow cytometry;  (Thermo Fisher)
    90
    Thermo Fisher dynabeads regulatory cd4 + cd25 + t-cell kit (>95% purity tested by flow cytometry;
    One-month nivolumab- CD3 + and KIR2DL2/DL3+ NKs predict response. A, Frequencies of CD3 + , <t>CD4</t> + , NKs and KIR2DL2/DL3+ NKs, and ICOS+ Tregs in R vs. NR patients. CD3 + T cells: 33 R vs. 22 NR, P < 0.05; CD4 + T cells: 33 R vs. 22 NR, P < 0.05; NKs: 31 R vs. 21 NR, P < 0.05; KIR2DL2/DL3+ NKs: 30 R vs. 21 NR, P < 0.05; ICOS+ Tregs: 23 R vs. 19 NR, P < 0.05. Two-tailed test comparison of differences between two independent groups ( P < 0.05). Box plot showing the data distribution across groups with minimum, median, and maximum values. Two-tailed test comparison of differences between two independent groups (*, P < 0.05; **, P < 0.01; ***, P < 0.001). B, Kaplan–Meier survival curves for PFS and OS of patients with mRCC-REV stratified according to optimal cutoff identified by ROC analyses. C, Kaplan–Meier plots showing PFS and OS of patients stratified according to a combination of CD3 + - KIR2DL2/DL3+ NKs. High–Low (black line); High–High (red line); Low–High (blue line); Low–Low (light blue line). P -values by long-rank test.
    Dynabeads Regulatory Cd4 + Cd25 + T Cell Kit (>95% Purity Tested By Flow Cytometry;, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dynabeads regulatory cd4 + cd25 + t-cell kit (>95% purity tested by flow cytometry;/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    dynabeads regulatory cd4 + cd25 + t-cell kit (>95% purity tested by flow cytometry; - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    t regulatory cell flow cytometry  (R&D Systems)
    93
    R&D Systems t regulatory cell flow cytometry
    One-month nivolumab- CD3 + and KIR2DL2/DL3+ NKs predict response. A, Frequencies of CD3 + , <t>CD4</t> + , NKs and KIR2DL2/DL3+ NKs, and ICOS+ Tregs in R vs. NR patients. CD3 + T cells: 33 R vs. 22 NR, P < 0.05; CD4 + T cells: 33 R vs. 22 NR, P < 0.05; NKs: 31 R vs. 21 NR, P < 0.05; KIR2DL2/DL3+ NKs: 30 R vs. 21 NR, P < 0.05; ICOS+ Tregs: 23 R vs. 19 NR, P < 0.05. Two-tailed test comparison of differences between two independent groups ( P < 0.05). Box plot showing the data distribution across groups with minimum, median, and maximum values. Two-tailed test comparison of differences between two independent groups (*, P < 0.05; **, P < 0.01; ***, P < 0.001). B, Kaplan–Meier survival curves for PFS and OS of patients with mRCC-REV stratified according to optimal cutoff identified by ROC analyses. C, Kaplan–Meier plots showing PFS and OS of patients stratified according to a combination of CD3 + - KIR2DL2/DL3+ NKs. High–Low (black line); High–High (red line); Low–High (blue line); Low–Low (light blue line). P -values by long-rank test.
    T Regulatory Cell Flow Cytometry, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/t regulatory cell flow cytometry/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    t regulatory cell flow cytometry - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    One-month nivolumab- CD3 + and KIR2DL2/DL3+ NKs predict response. A, Frequencies of CD3 + , CD4 + , NKs and KIR2DL2/DL3+ NKs, and ICOS+ Tregs in R vs. NR patients. CD3 + T cells: 33 R vs. 22 NR, P < 0.05; CD4 + T cells: 33 R vs. 22 NR, P < 0.05; NKs: 31 R vs. 21 NR, P < 0.05; KIR2DL2/DL3+ NKs: 30 R vs. 21 NR, P < 0.05; ICOS+ Tregs: 23 R vs. 19 NR, P < 0.05. Two-tailed test comparison of differences between two independent groups ( P < 0.05). Box plot showing the data distribution across groups with minimum, median, and maximum values. Two-tailed test comparison of differences between two independent groups (*, P < 0.05; **, P < 0.01; ***, P < 0.001). B, Kaplan–Meier survival curves for PFS and OS of patients with mRCC-REV stratified according to optimal cutoff identified by ROC analyses. C, Kaplan–Meier plots showing PFS and OS of patients stratified according to a combination of CD3 + - KIR2DL2/DL3+ NKs. High–Low (black line); High–High (red line); Low–High (blue line); Low–Low (light blue line). P -values by long-rank test.

    Journal: Clinical Cancer Research

    Article Title: KIR2DL2/DL3+ NKs and Helios+ Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer

    doi: 10.1158/1078-0432.CCR-24-0729

    Figure Lengend Snippet: One-month nivolumab- CD3 + and KIR2DL2/DL3+ NKs predict response. A, Frequencies of CD3 + , CD4 + , NKs and KIR2DL2/DL3+ NKs, and ICOS+ Tregs in R vs. NR patients. CD3 + T cells: 33 R vs. 22 NR, P < 0.05; CD4 + T cells: 33 R vs. 22 NR, P < 0.05; NKs: 31 R vs. 21 NR, P < 0.05; KIR2DL2/DL3+ NKs: 30 R vs. 21 NR, P < 0.05; ICOS+ Tregs: 23 R vs. 19 NR, P < 0.05. Two-tailed test comparison of differences between two independent groups ( P < 0.05). Box plot showing the data distribution across groups with minimum, median, and maximum values. Two-tailed test comparison of differences between two independent groups (*, P < 0.05; **, P < 0.01; ***, P < 0.001). B, Kaplan–Meier survival curves for PFS and OS of patients with mRCC-REV stratified according to optimal cutoff identified by ROC analyses. C, Kaplan–Meier plots showing PFS and OS of patients stratified according to a combination of CD3 + - KIR2DL2/DL3+ NKs. High–Low (black line); High–High (red line); Low–High (blue line); Low–Low (light blue line). P -values by long-rank test.

    Article Snippet: PB-derived CD4 + CD25 + Tregs and PB-derived CD4 + CD25 − T effector cells (Teffs) were isolated from fresh PBMCs using the Dynabeads Regulatory CD4 + CD25 + T-cell kit (>95% purity tested by flow cytometry; Invitrogen by Life Technologies, Cat. #11363D).

    Techniques: Two Tailed Test, Comparison